To evaluate the utility of 89Zr-ivuxolimab for in vivo detection of activated T cells, we used a modified model of acute GvHD, designed to introduce expression of human OX40 onto murine T cells. The gene discussed is TNFRSF4; the disease is graft versus host disease.